ClinicalTrials.Veeva

Menu

Caffeinated Chewing Gum on 400-meter Performance

C

Chih-Hui Chiu

Status

Completed

Conditions

Caffeine
Placebo

Treatments

Dietary Supplement: caffeine

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

Details and patient eligibility

About

20 trained sprinter were divided into caffeine Gum trial (CAF) and Placebo trial (PL) with a randomized, double-blind study design. The participants chewing either caffeine Gum (CAF trial, containing 3 mg/kg of caffeine) or Placebo Gum (PL) for 10 minutes. The outcomes are Running-Based Anaerobic Sprint Test and 400-meter sprint test was performed.

Full description

The purpose of this study was to investigate the effect of caffeinated chewing gum on 400-meter sprint performance. 20 trained sprinter were divided into caffeine Gum trial (CAF) and Placebo trial (PL) with a randomized, double-blind study design. The participants chewing either caffeine Gum (CAF trial, containing 3 mg/kg of caffeine) or Placebo Gum (PL) for 10 minutes. After rested for 15 minutes, the participants underwent a Running-Based Anaerobic Sprint Test. After a 30-minute break, a 400-meter sprint test was performed. The blood lactate concentration were collected before and after 400-meter sprint from finger. Saliva samples were predicted to be collected before chewing gum, before the RAST, and after a 400-meter sprint. Saliva samples will be analyzed for caffeine and α-amylase concentrations in saliva.

Enrollment

19 patients

Sex

Male

Ages

20 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 6 years of professional short sprinting training
  • 6 months of ongoing training, and
  • 3 months of recovery from sports injuries such as strains and sprains.

Exclusion criteria

  • Non-specialized sprinters.
  • has not trained regularly for the past 6 months.
  • has recovered from an athletic injury.
  • less than 3 months of recovery from a sports injury, or participants with epilepsy, hypertension, hyperlipidemia, heart disease, arthritis, osteoporosis, brain injury, or a history of caffeine allergy.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

19 participants in 2 patient groups, including a placebo group

caffeine gum
Experimental group
Description:
The participants chewing caffeine gum 10 minutes before exercise
Treatment:
Dietary Supplement: caffeine
placebo gum
Placebo Comparator group
Description:
The participants chewing placebo gum 10 minutes before exercise
Treatment:
Dietary Supplement: caffeine

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems